The tyrosine kinase inhibitor dasatinib effectively blocks PDGF-induced orbital fibroblast activation.

Virakul, Sita; Dalm, Virgil A S H; Paridaens, Dion; van den Bosch, Willem A; Hirankarn, Nattiya; van Hagen, P Martin; Dik, Willem A.
Graefes Arch Clin Exp Ophthalmol; 252(7): 1101-9, 2014 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-24874745